与其他三种商业化一次性胰岛素笔相比，Gla-300注射装置的易用性：基于访谈的调查结果。 - Suppr

Suppr

超能文献

Usability of the Gla-300 Injection Device Compared With Three Other Commercialized Disposable Insulin Pens: Results of an Interview-Based Survey.

作者信息

Klonoff David, Nayberg Irina, Erbstein Frank, Cali Anna, Brulle-Wohlhueter Claire, Haak Thomas

机构信息

Diabetes Research Institute, Mills-Peninsula Health Services, San Mateo, CA, USA

Diabetes Research Institute, Mills-Peninsula Health Services, San Mateo, CA, USA.

出版信息

J Diabetes Sci Technol. 2015 Jul;9(4):936-8. doi: 10.1177/1932296815586219. Epub 2015 May 22.

DOI:10.1177/1932296815586219

PMID:26002837

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4525641/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ee8/4525641/aef9311abe46/10.1177_1932296815586219-fig1.jpg

相似文献

Usability of the Gla-300 Injection Device Compared With Three Other Commercialized Disposable Insulin Pens: Results of an Interview-Based Survey.

J Diabetes Sci Technol. 2015 Jul;9(4):936-8. doi: 10.1177/1932296815586219. Epub 2015 May 22.

Accuracy and Injection Force of the Gla-300 Injection Device Compared With Other Commercialized Disposable Insulin Pens.

J Diabetes Sci Technol. 2015 Aug 26;10(1):125-30. doi: 10.1177/1932296815601441.

Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study.

Clin Ther. 2007 Apr;29(4):650-60. doi: 10.1016/j.clinthera.2007.04.003.

Effect of insulin pen devices on the management of diabetes mellitus.

Am J Health Syst Pharm. 2008 Jun 1;65(11):1076-82. doi: 10.2146/ajhp070524.

Insulin pens: the modern delivery devices.

J Assoc Physicians India. 2011 Apr;59 Suppl:38-40.

Dose accuracy and injection force dynamics of a novel disposable insulin pen.

Expert Opin Drug Deliv. 2007 Mar;4(2):165-74. doi: 10.1517/17425247.4.2.165.

FlexTouch® for the delivery of insulin: technical attributes and perception among patients and healthcare professionals.

Expert Rev Med Devices. 2012 May;9(3):209-17. doi: 10.1586/erd.12.13. Epub 2012 Apr 3.

Humalog(®) KwikPen™: an insulin-injecting pen designed for ease of use.

Expert Rev Med Devices. 2010 Nov;7(6):735-43. doi: 10.1586/erd.10.63.

Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes.

Diabetes Technol Ther. 2014 Feb;16(2):76-83. doi: 10.1089/dia.2013.0172. Epub 2013 Nov 23.

[Evaluation of a new disposable insulin pen and injection habits of diabetes patients in everyday clinical practice].

MMW Fortschr Med. 2010 Jan 14;151 Suppl 4:179-87.

引用本文的文献

Clinical Use of Insulin Glargine 300 U/mL in Adults with Type 2 Diabetes: Hypothetical Case Studies.

Diabetes Ther. 2022 May;13(5):913-930. doi: 10.1007/s13300-022-01247-7. Epub 2022 Mar 30.

Efficacy and Safety of Switching Patients Inadequately Controlled on Basal Insulin to Insulin Glargine 300 U/mL: The TRANSITION 2 Study.

Diabetes Ther. 2020 Jan;11(1):147-159. doi: 10.1007/s13300-019-00734-8. Epub 2019 Nov 28.

Efficacy and Safety of Switching from Insulin Glargine 100 U/mL to the Same Dose of Glargine 300 U/mL in Japanese Type 1 and 2 Diabetes Patients: A Retrospective Analysis.

Intern Med. 2018;57(10):1381-1389. doi: 10.2169/internalmedicine.9334-17. Epub 2018 May 15.

Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience.

Diabetes Metab Syndr Obes. 2017 Dec 15;10:521-532. doi: 10.2147/DMSO.S143046. eCollection 2017.

Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus.

Diabetes Metab Syndr Obes. 2017 Jun 30;10:273-284. doi: 10.2147/DMSO.S131358. eCollection 2017.

Patients' Preferences for Insulin Injection Devices.

J Diabetes Sci Technol. 2017 Mar;11(2):270-271. doi: 10.1177/1932296816688014. Epub 2017 Jan 9.

rDNA insulin glargine U300 - a critical appraisal.

Diabetes Metab Syndr Obes. 2016 Dec 2;9:425-441. doi: 10.2147/DMSO.S87873. eCollection 2016.

Clinical Pharmacokinetics and Pharmacodynamics of Insulin Glargine 300 U/mL.

Clin Pharmacokinet. 2017 May;56(5):449-458. doi: 10.1007/s40262-016-0464-6.

Ease of Use of the Insulin Glargine 300 U/mL Pen Injector in Insulin-Naïve People With Type 2 Diabetes.

J Diabetes Sci Technol. 2017 Mar;11(2):263-269. doi: 10.1177/1932296816668877. Epub 2016 Sep 25.

Insulin Glargine 300 U/mL: A Review in Diabetes Mellitus.

Drugs. 2016 Mar;76(3):363-74. doi: 10.1007/s40265-016-0541-z.

本文引用的文献

New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3).

Diabetes Obes Metab. 2015 Apr;17(4):386-94. doi: 10.1111/dom.12438. Epub 2015 Feb 12.

New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 2).

Diabetes Care. 2014 Dec;37(12):3235-43. doi: 10.2337/dc14-0990. Epub 2014 Sep 5.

New insulin glargine 300 Units · mL-1 provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 Units · mL-1.

Diabetes Care. 2015 Apr;38(4):637-43. doi: 10.2337/dc14-0006. Epub 2014 Aug 22.

New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using basal and mealtime insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 1).

Diabetes Care. 2014 Oct;37(10):2755-62. doi: 10.2337/dc14-0991. Epub 2014 Jul 30.

What can we learn from patient-reported outcomes of insulin pen devices?

J Diabetes Sci Technol. 2011 Nov 1;5(6):1563-71. doi: 10.1177/193229681100500633.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验